1. 長岡 功, Niyonsaba F, 石井(堤)裕子. Defensin. Surgery Frontier 7: 293-296, 2000.

2. 長岡 功, 石井(堤)裕子, Niyonsaba F. Defensinの感染防御と免疫応答における役割. 臨床免疫 33: 557-565, 2000.

3. Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I. Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells. Eur J Immunol 31: 1066-1075, 2001.

4. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells. J Immunol 167: 3329-3338, 2001.

5. Niyonsaba F, 平田陸正, 長岡 功. 殺菌ペプチドの肥満細胞に及ぼす影響. 炎症・再生 21: 109-115, 2001.

6. 石井(堤)裕子, Niyonsaba F, 長岡 功. 殺菌ペプチドdefensinとcathelicidinの生体防御における役割. 感染 炎症 免疫 31: 326-329, 2001.

7. 長岡 功, Niyonsaba F. デフェンシンのマスト細胞刺激作用. 臨床免疫 36: 290-296, 2001.

8. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I. Epithelial cell-derived human β-defensin-2 acts as chemotaxin for mast cells through pertussis toxin-sensitive and phospholipase C-dependent pathway. Int Immunol 14: 421-426, 2002.

9. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cells chemotaxis. Immunology 106: 20-26, 2002.

10. Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Tanaka S, Heumann D. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 9: 972-982, 2002.

11. 長岡 功, 廣田聡子, Niyonsaba F, 田村弘志, 田中重則, 平田陸正. Cathelicidinファミリーの殺菌ペプチドLL-37, CAP11のLPS中和作用. 炎症・再生 22: 131-138, 2002.

12. Niyonsaba F, Hirata M, Ogawa H, Nagaoka I. Epithelial cell-derived antibacterial peptides human β-defensins and cathelicidin: multifunctional activities on mast cells. Curr Drug Targets Inflamm Allergy 2: 224-231, 2003.

13. Niyonsaba F, Ogawa H, Nagaoka I. Human β-defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils. Immunology 111: 273-281, 2004.

14. Sampanthanarak P, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. The effect of antibacterial peptide human β-defensin-2 on interleukin-18 secretion by keratinocytes. J Dermatol Sci 37: 188-191, 2005.

15. Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 40: 123-132, 2005.

16. Niyonsaba F, Ushio H, Nagaoka I, Okumura K, Ogawa H. The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 kinase and ERK MAPK activation in primary human keratinocytes. J Immunol 175: 1776-1784, 2005.

17. Niyonsaba F, Ogawa H. Protective roles of the skin against infection: Implication of naturally occurring human antibacterial agents β-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci 40: 157-168, 2005.

18. Defensive properties of the skin against infection: Implication of antibacterial agents human β-defensins, cathelicidin and lysozyme. 難治性皮膚疾患の病態と治療：皮膚の感染防御機構．小川秀興　編集, 吉川出版, 東京, 252-259, 2005.

19. Niyonsaba F, Nagaoka I, Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 26: 545-576, 2006.

20. Yokoi H, Okayama Y, Niyonsaba F, Fujimori M, Enomoto F, Yoshikawa H, Ikeda K, Saito H. Comparison of human tonsillar mast cell localization and ultrastructural observations between IgE-mediated allergic and non-allergic donors. Allergy Asthma Proc 27: 415-421, 2006.

21. Chen X, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells. J Dermatol Sci 43: 63-66, 2006.

22. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127: 594-604, 2007.

23. Chen X, Niyonsaba F, Ushio H, Hara M, Yokoi H, Matsumoto K, Saito H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 37: 434-444, 2007.

24. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana STM, Ikeda S, Okumura K, Ogawa H. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 82: 657-665, 2007.

25. Zheng Y, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α-defensins from neutrophils. Br J Dermatol 157: 1124-1131, 2007.

26. Ogawa T, Takai T, Kato T, Kikuchi Y, Niyonsaba F, Ikeda S, Okumura K, Ogawa H. Upregulation of the release of granulocyte-macrophage colony-stimulating factor from keratinocytes stimulated with cysteine protease activity of recombinant major mite allergens, Der f 1 and Der p 1. Int Arch Allergy Immunol 146: 27-35, 2007.

27. 長岡　功, Niyonsaba F. 抗菌ペプチドとその作用メカニズム.　臨床検査 51: 1037-1045, 2007.

28. Jayawardana ST, Ushio H, Niyonsaba F, Gondokaryono SP, Takenaka H, Ikeda S, Okumura K, Ogawa H. Monomeric IgE and lipopolysaccharide synergistically prevent mast-cell apoptosis. Biochem Biophys Res Commun 365: 137-142, 2008.

29. Zheng Y, Niyonsaba F, Ushio H, Ikeda S, Nagaoka I, Okumura K, Ogawa H. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 124: 357-367, 2008.

30. Nagaoka I, Niyonsaba F, Tsutsumi-Ishii Y, Tamura H, Hirata M. Evaluation of the effect of human β-defensins on neutrophil apoptosis. Int Immunol 20: 543-553, 2008.

31. Ishikawa Y, Tokura T, Nakano N, Hara M, Niyonsaba F, Ushio H, Yamamoto Y, Tadokoro T, Okumura K, Ogawa H. Inhibitory effect of honeybee-collected pollen on mast cell degranulation in vivo and in vitro. J Med Food 11: 14-20, 2008.

32. Niyonsaba F, Hattori F, Maeyama K, Ogawa H, Okamoto K. Induction of a microbicidal protein psoriasin (S100A7), and its stimulatory effects on normal human keratinocytes. J Dermatol Sci 52: 216-219, 2008.

33. Niyonsaba F, Suzuki A, Ushio H, Nagaoka I, Ogawa H, Okumura K. The human antimicrobial peptide dermcidin activates normal human keratinocytes. Br J Dermatol 160: 243-249, 2009.

34. Ishikawa Y, Tokura T, Ushio H, Niyonsaba F, Yamamoto Y, Tadokoro T, Ogawa H, Okumura K. Lipid-soluble components of honeybee-collected pollen exert antiallergic effect by inhibiting IgE-mediated mast cell activation in vivo. Phytother Res 23: 1581-1586, 2009.

35. Niyonsaba F, Nagaoka I, Ogawa H, Okumura K. Multifunctional antimicrobial proteins and peptides: Natural activators of immune systems. Curr Pharm Des 15: 2393-2413, 2009.

36. Takenaka H, Ushio H, Niyonsaba F, Jayawardana ST, Hajime S, Ikeda S, Ogawa H, Okumura K. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem Biophys Res Commun 391: 471-476, 2010.

37. Niyonsaba F, Ushio H, Hara M, Yokoi H, Tominaga M, Takamori K, Kajiwara N, Saito H, Nagaoka I, Ogawa H, Okumura K. Antimicrobial peptides human β-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine interleukin-31 by human mast cells. J Immunol 184: 3526-3534, 2010.

38. Nagaoka I, Suzuki K, Murakami T, Niyonsaba F, Tamura H, Hirata M. Evaluation of the effect of α-defensins human neutrophil peptides on neutrophil apoptosis. Int J Mol Med 26: 925-934, 2010.

39. Aung G, Niyonsaba F, Ushio H, Hoq MI, Ikeda S, Ogawa H, Okumura K.　A neuroendocrine antimicrobial peptide, catestatin, stimulates interleukin-8 production from human keratinocytes via activation of mitogen-activated protein kinases.J Dermatol Sci 61: 142-144, 2011.

40. Aung G, Niyonsaba F, Ushio H, Kajiwara N, Saito H, Ikeda S, Ogawa H, Okumura K. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology 132: 527-539, 2011.

41. Ushio H, Ueno T, Kojima Y, Komatsu M, Tanaka S, Yamamoto A, Ichimura Y, Ezaki J, Nishida K, Komazawa-Sakon S, Niyonsaba F, Ishii T, Yanagawa T, Kominami E, Ogawa H, Okumura K, Nakano H. Crucial role for autophagy in degranulation of mast cells. J Allergy Clin Immunol 127: 1267-1276, 2011.

42. Kawasaki J, Ushio H, Kinoshita H, Fukai T, Niyonsaba F, Takai T, Ogawa H, Okumura K, Ikeda S. Viral infection induces thymic stromal lymphopoietin (TSLP) in human keratinocytes. J Dermatol Sci 62: 131-134, 2011.

43. Aung G, Niyonsaba F, Ushio H, Ikeda S, Okumura K, Ogawa H. Elafin and secretory leukocyte protease inhibitor stimulate the production of cytokines and chemokines by human keratinocytes via MAPK/ERK and NF-κB activation. J Dermatol Sci 63: 128-131, 2011.

44. Hoq MI, Niyonsaba F, Ushio H, Aung G, Okumura K, Ogawa H. Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes. J Dermatol Sci 64: 108-118, 2011.

45. Baba Y, Maeda K, Yashiro T, Inage E, Niyonsaba F, Hara M, Suzuki R, Ohtsuka Y, Shimizu T, Ogawa H, Okumura K, Nishiyama C. Involvement of PU.1 in mast cell/basophil-specific function of the human IL1RL1/ST2 promoter. Allergol Int 61: 461-467, 2012.

46. Baba Y, Maeda K, Yashiro T, Inage E, Kasakura K, Suzuki R, Niyonsaba F, Hara M, Tanabe A, Ogawa H, Okumura K, Ohtsuka Y, Shimizu T, Nishiyama C. GATA2 is critical transactivator for human IL1RL1/ST2 promoter in mast cells/basophils: opposing roles for GATA2 and GATA1 in human IL1RL1/ST2 gene expression. J Biol Chem 287: 32689-32696, 2012.

47. Nguyen TT, Niyonsaba F, Ushio H, Akiyama T, Kiatsurayanon C, Smithrithee R, Ikeda S, Okumura K, Ogawa H. Interleukin-36 cytokines enhance the production of host defense peptides psoriasin and LL-37 by human keratinocytes through activation of MAPKs and NF-κB. J Dermatol Sci 68: 63-66, 2012.

48. Nagaoka I, Suzuki K, Niyonsaba F, Tamura H, Hirata M. Modulation of neutrophil apoptosis by antimicrobial peptides. ISRN Microbiology 2012, 1-12, 2012.

49. Fukuda M, Ushio H, Kawasaki J, Niyonsaba F, Takeuchi M, Baba T, Hiramatsu K, Okumura K, Ogawa H. Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection. J Innate Immun 5: 163-173, 2013.

50. Niyonsaba F, Madera L, Okumura K, Ogawa H, Hancock REW. The innate defense regulator peptides IDR-HH2, IDR-1002 and IDR-1018 modulate human neutrophil functions. J Leukoc Biol 94: 159-170, 2013.

51. Chen X, Takai T, Xie Y, Niyonsaba F, Okumura K, Ogawa H. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochem Biophys Res Commun 433: 532-537, 2013.

52. Umehara Y, Hanaoka K and Watanabe D. Distinct functions of Dnmt3a and Dnmt3b de novo DNA methyltransferases in ES cell proliferation and differentiation. Stem Cell Discovery 3: 127-132, 2013.

53. Hattori F, Kiatsurayanon C, Okumura K, Ogawa H, Ikeda S, Okamoto K, Niyonsaba F. The antimicrobial protein S100A7/psoriasin enhances expression of keratinocyte differentiation markers and strengthens the skin tight junction barrier. Br J Dermatol 171: 742-753, 2014.

54. Akiyama T, Niyonsaba F, Kiatsurayanon C, Nguyen TT, Ushio H, Fujimura T, Ueno T, Okumura K, Ogawa H, Ikeda S. The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J Innate Immun 6: 739-753, 2014.

55. Kiatsurayanon C, Niyonsaba F, Smithrithee R, Akiyama T, Ushio H, Okumura K, Ikeda S, Ogawa H. Host defense (antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight junction barrier in human keratinocytes. J Invest Dermatol 134: 2163-2173, 2014.

56. Inage E, Kasakura K, Yashiro T, Suzuki R, Baba Y, Nakano N, Hara M, Tanabe A, Oboki K, Matsumoto K, Saito H, Niyonsaba F, Ohtsuka Y, Ogawa H, Okumura K, Shimizu T, Nishiyama C. Critical roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2. J Immunol 192: 3936-3946, 2014.

57. Kamata Y, Tominaga M, Umehara Y, Negi O, Ogawa H, Takamori K. Retinoid-related orphan receptor alpha is involved in semaphorin 3A expression in normal human epidermal keratinocytes. J Dermatol Sci 79:84-86, 2015.

58. Tominaga M, Kamata Y, Umehara Y, Ko KC, Takamori K. Mechanisms of itch in atopic dermatitis. J Environ Dermatol Cutan Allergol. Vol. 9, 1-11. 2015.

59. Smithrithee R, Niyonsaba F, Kiatsurayanon C, Ushio H, Ikeda S, Okumura K, Ogawa H. Human β-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes. J Dermatol Sci 77: 46-53, 2015.

60. Tsutsui-Takeuchi M, Ushio H, Fukuda M, Yamada T, Niyonsaba F, Okumura K, Ogawa H, Ikeda S. Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2′-5′ oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection. Immunol Res, 61: 240-249, 2015.

61. Umehara Y, Kamata Y, Tominaga M, Niyonsaba F, Ogawa H, Takamori K. Cathelicidin LL-37 induces semaphorin 3A expression in human epidermal keratinocytes: implications for possible application to pruritus. J Invest Dermatol 135: 2887-2890, 2015.

62. Kanazawa K, Okumura K, Ogawa H, Niyonsaba F. An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways. Immunol Res 64: 594-603, 2016.

63. Kiatsurayanon C, Niyonsaba F, Chieosilapatham P, Okumura K, Ikeda S, Ogawa H. Angiogenic peptide (AG)-30/5C activates human keratinocytes to produce cytokines/chemokines and to migrate and proliferate via MrgX receptors. J Dermatol Sci 83: 190-199, 2016.

64. Niyonsaba F. Novel insight into the role of antimicrobial (host defense) peptides/proteins in human skin diseases. Juntendo Med J 62: 120-131, 2016.

65. Niyonsaba F, Kiatsurayanon C, Ogawa H. The role of human β-defensins in allergic diseases. Clin Exp Allergy 46: 1522-1530, 2016.

66. ニヨンサバ　フランソワ.ヒトβ-ディフェンシン類とアレルギー性疾患.臨床免疫・アレルギー科 66: 146-151, 2016.

67. Takamori K, Tominaga M, Kamata Y, Kamo A, Umehara Y, Negi O, Suga Y. Mechanisms and management of intractable itch in atopic dermatitis. Juntendo Med J 62:285-289, 2016.

68. 冨永光俊，加茂敦子，鎌田弥生，梅原芳恵，高森建二. 皮膚疾患と痒み. アレルギー・免疫. Vol. 23, No. 9, 1230-1242, 2016.

69. 鎌田弥生，冨永光俊，梅原芳恵，髙森建二. 神経反発因子に着眼したアトピー性皮膚炎のかゆみ治療薬の開発. アレルギーの臨床. Vol. 36, No. 9, 58-63, 2016.

70. Kamata Y, Kimura U, Matsuda H, Tengara S, Kamo A, Umehara Y, Iizumi K, Kawasaki H, Suga Y, Ogawa H, Tominaga M, Takamori K. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis. J Dermatol Sci 84:266-27, 2016.

71. Kamo A, Tominaga M, Matsuda H, Kina K, Kamata Y, Umehara Y, Ogawa H, Takamori K. Neurotropin suppresses itch-related behavior in NC/Nga mice with atopic dermatitis-like symptoms. J Dermatol Sci 81:212-5, 2016.

72. Ko KC, Tominaga M, Kamata Y, Umehara Y, Matsuda H, Takahashi N, Kina K, Ogawa M, Ogawa H, Takamori K. Possible anti-pruritic mechanisms of cyclosporine A in atopic dermatitis. Acta Derm Venereol 96:624-9, 2016.

73. ニヨンサバ　フランソワ. 抗菌ペプチドと皮膚疾患. Bio Industry, 34 (9): 44-52, 2017.

74. Chieosilapatham P, Niyonsaba F, Kiatsurayanon C, Okumura K, Ikeda S, Ogawa H. The antimicrobial peptide derived from insulin-like growth factor-binding protein 5, AMP-IBP5, regulates keratinocyte functions through Mas-related gene X receptors. J Dermatol Sci 88: 117-125, 2017.

75. Umehara Y, Kamata Y, Tominaga M, Niyonsaba F, Ogawa H, Takamori K. Antimicrobial peptides human LL-37 and β-defensin-3 modulate the expression of nerve elongation factors in human epidermal keratinocytes. J Dermatol Sci 88: 365-367, 2017.

76. Yanashima K, Chieosilapatham P, Yoshimoto E, Okumura K, Ogawa H, Niyonsaba F. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-κB-sensitive pathways. Immunol Res 65: 920-931, 2017.

77. Kiatsurayanon C, Rojanamatin J, Sudtikoonaseth P, Kampirapap K, Wichaidit M, Niyonsaba F. Unilateral linear punctate palmoplantar keratoderma: a case report. Case Rep Dermatol 9:86–89, 2017.

78. Niyonsaba F, Kiatsurayanon C, Chieosilapatham P, Ogawa H. Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases. Exp Dermatol 26: 989-998, 2017.

79. Chieosilapatham P, Ogawa H, Niyonsaba F. Current insights into the role of human β-defensins in atopic dermatitis. Clin Exp Immunol 190: 155-166, 2017.

80. 抗菌ペプチドの機能解明と技術利用. 長岡　功　監修, シーエムシー出版, 176-183, 2017.

81. Takahashi N, Tominaga M, Kosaka R, Kamata Y, Umehara Y, Matsuda H, Sakaguchi A, Ogawa H, Takamori K. Involvement of µ-opioid Receptors and κ-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice. Acta Derm Venereol 97:928-933, 2017.

82. Sakaguchi A, Kamata Y, Takahashi N, Matsuda H, Kosaka R, Umehara Y, Ogawa H, Tominaga M, Takamori K. Oral administration of milk-derived phospholipids inhibits a penetration of cutaneous nerve fibers into epidermis in an acute dry skin model mouse. Clin Exp Dermatol 42:890-894, 2017.

83. Noguchi A, Tominaga M, Takahashi N, Matsuda H, Kamata Y, Umehara Y, Ko KC, Suga Y, Ogawa H, Takamori K. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. J Dermatol Sci 86:54-62, 2017.

84. Kamata Y, Sakaguchi A, Umehara Y, Suga Y, Ogawa H, Tominaga M, Takamori K. Bepotastine besilate downregulates the expression of nerve elongation factors in normal human epidermal keratinocytes. J Dermatol Sci 91:219-222, 2018.

85. Kiatsurayanon C, Ogawa H, Niyonsaba F. The role of host defense peptide human β-defensins in the maintenance of skin barriers. Curr Pharm Des 24: 1079-1091, 2018.

86. Chieosilapatham P, Ikeda S, Ogawa H, Niyonsaba F. Tissue-specific regulation of innate immune responses by human cathelicidin LL-37. Curr Pharm Des 24: 1092-1099, 2018.

87. Sekihara K, Saitoh K, Yang H, Kawashima H, Kazuno S, Kikkawa M, Arai H, Miida T, Hayashi N, Niyonsaba F, Sasai K, Tabe Y. Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines. PLoS One 13: e0205581, 2018.

88. Murakami T, Suzuki K, Niyonsaba F, Tada H, Reich J, Tamura H, Nagaoka I. MrgX2‑mediated internalization of LL‑37 and degranulation of human LAD2 mast cells. Mol Med Rep 18: 4951-4959, 2018.

89. Niyonsaba F, Song P, Yue H, Sutthammikorn N, Umehara Y, Okumura K, Ogawa H. Antimicrobial peptide derived from insulin-like growth factor-binding protein 5 activates mast cells via Mas-related G protein-coupled receptor X2. Allergy 75:203-207, 2020.

90. Umehara Y, Toyama S, Tominaga M, Matsuda H, Takahashi N, Kamata Y, Niyonsaba F, Ogawa H, Takamori K: Robust induction of neural crest cells to derive peripheral sensory neurons from human induced pluripotent stem cells. Sci Rep. 10:4360, 2020.

91. Kiatsurayanon C, Niyonsaba F. Comorbidities in atopic dermatitis. In Andreas Maur. Atopic dermatitis: from diagnosis to treatment (Chapter 2). New York, USA: Nova Science Publishers.2020

92. Peng G, Niyonsaba F. Emerging therapies for atopic dermatitis. In Andreas Maur. Atopic dermatitis: from diagnosis to treatment (Chapter 4). New York, USA: Nova Science Publishers.2020

93. Kamata Y, Tominaga M, Umehara Y, Honda K, Kamo A, Moniaga CS, Komiya E, Toyama S, Suga Y, Ogawa H, Takamori K. Calcium-inducible MAPK/AP-1 signaling drives semaphorin 3A expression in normal human epidermal keratinocytes. J Invest Dermatol 140:1346–1354.e5, 2020.

94. Kamo A, Umehara Y, Negi O, Iwata M, Kamata Y, Suga Y, Ogawa H, Tominaga M, Takamori K. Effects of Kakato-tsurutsuru socks on dry heels in healthy volunteer subjects. J Dermatol 47:413-417, 2020.

95. Chieosilapatham P, Yue H, Ikeda S, Ogawa H, Niyonsaba F. Involvement of the lipoprotein receptor LRP1 in AMP-IBP5-mediated migration and proliferation of human keratinocytes and fibroblasts. J Dermatol Sci, 2020 (In press).

96. Niyonsaba F, Takahashi M,Ikutama R. Novel insights into the pathophysiology of atopic dermatitis. Juntendo Med J, 2020 (In press).

97. Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez V, Peng G, Yue H, Nguyen HLT, Niyonsaba F. Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol, 2020 (In press).

98. Umehara Y, Kiatsurayanon C, Trujillo-Paez JV, Chieosilapath P, Peng G, Yue H, Nguyen HLT, Song P, Okumura K, Ogawa H, Niyonsaba F. Mechanisms and treatment of itch in atopic dermatitis. Exp Dermatol, 2020 (In press).

99. Nguyen HLT, Trujillo-Paez JV, Umehara Y, Yue H, Peng G, Kiatsurayanon C, Chieosilapath P, Song P, Okumura K, Ogawa H, Ikeda S, Niyonsaba F. Role of antimicrobial peptides in skin barrier repair in atopic dermatitis. Int J Mol Sci, 2020 (In press).

100. ニヨンサバ　フランソワ, 高橋　美帆, 生玉　梨沙. アトピー性皮膚炎発症機序に対する新知見.臨床免疫・アレルギー科, 2020（In press）.